Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislav Volik

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Nature Genetics|October 2, 2002
Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumorsGiuseppe Zardo, Maarit I Tiirikainen, Chibo Hong, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2003
End-sequence profiling: sequence-based analysis of aberrant genomesStanislav Volik, Shaying Zhao, Koei Chin, et al.
Molecular Cancer Therapeutics|March 10, 2025
5'-S-(3-aminophenyl)-5'-thioadenosine, a novel chemoprotective agent for reducing toxic side effects of fluorouracil in treatment of MTAP-deficient cancersSi Zhang, Hui Xue, Nelson K Y Wong, et al.
Cancer Cell International|January 15, 2019
Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic targetMarta Llaurado Fernandez, Amy Dawson, Joshua Hoenisch, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
AR-V7 condensates drive androgen-independent transcription in castration resistant prostate cancerShabnam Massah, Nicholas Pinette, Jane Foo, et al.
Circulation. Genomic and Precision Medicine|January 24, 2025
Atrial Fibrillation Related Titin Truncation Is Associated With Atrial Myopathy in Patient-Derived Induced Pluripotent Stem Cell Disease ModelsKate Huang, Mishal Ashraf, Leili Rohani, et al.
International Journal of Molecular Sciences|February 27, 2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational StatusMadison Bittner, Marta Llaurado Fernandez, Joshua Hoenisch, et al.
Translational Oncology|November 7, 2025
Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterationsNelson K Y Wong, Marta Llaurado Fernandez, Hannah Kim, et al.
Oncogene|March 10, 2004
Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancerJ E Vivienne Watson, Norman A Doggett, Donna G Albertson, et al.
Genome Research|February 8, 2006
Decoding the fine-scale structure of a breast cancer genome and transcriptomeStanislav Volik, Benjamin J Raphael, Guiqing Huang, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Nature Genetics|October 2, 2002
Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumorsGiuseppe Zardo, Maarit I Tiirikainen, Chibo Hong, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2003
End-sequence profiling: sequence-based analysis of aberrant genomesStanislav Volik, Shaying Zhao, Koei Chin, et al.
Molecular Cancer Therapeutics|March 10, 2025
5'-S-(3-aminophenyl)-5'-thioadenosine, a novel chemoprotective agent for reducing toxic side effects of fluorouracil in treatment of MTAP-deficient cancersSi Zhang, Hui Xue, Nelson K Y Wong, et al.
Cancer Cell International|January 15, 2019
Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic targetMarta Llaurado Fernandez, Amy Dawson, Joshua Hoenisch, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
AR-V7 condensates drive androgen-independent transcription in castration resistant prostate cancerShabnam Massah, Nicholas Pinette, Jane Foo, et al.
Circulation. Genomic and Precision Medicine|January 24, 2025
Atrial Fibrillation Related Titin Truncation Is Associated With Atrial Myopathy in Patient-Derived Induced Pluripotent Stem Cell Disease ModelsKate Huang, Mishal Ashraf, Leili Rohani, et al.
International Journal of Molecular Sciences|February 27, 2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational StatusMadison Bittner, Marta Llaurado Fernandez, Joshua Hoenisch, et al.
Translational Oncology|November 7, 2025
Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterationsNelson K Y Wong, Marta Llaurado Fernandez, Hannah Kim, et al.
Oncogene|March 10, 2004
Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancerJ E Vivienne Watson, Norman A Doggett, Donna G Albertson, et al.
Genome Research|February 8, 2006
Decoding the fine-scale structure of a breast cancer genome and transcriptomeStanislav Volik, Benjamin J Raphael, Guiqing Huang, et al.
Pageof 3